Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition

AIDS

Volumn 27, Issue 11, 2013, Pages 1763-1770

  Novak, Richard M ^a   Metch, Barbara ^b   Buchbinder, Susan ^c   Cabello, Robinson ^d   Donastorg, Yeycy ^e   Figoroa, John Peter ^f   Adbul Jauwad, Hend ^a   Joseph, Patrice ^g   Koenig, Ellen ^h   Metzger, David ⁱ   Sobieszycz, Magda ^j   Tyndall, Mark ^k   Zorilla, Carmen ^l  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^d VIA LIBRE ^*  (Peru)

^e Dirección Nacional de Control de Infecciones de Transmisión Sexual y SIDA   (Dominican Republic)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

^g Department of Adolescent Medicine   (Haïti)

^h Instituto Dominicano de Estudios Virologicos   (Dominican Republic)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j NewYork Presbyterian Hospital   (United States)

^k UNIVERSITY OF OTTAWA   (Canada)

^l UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

more..

Author keywords

HIV prevention; HIV vaccine; pregnancy; risk behavior; women

Indexed keywords

ADENOVIRUS VECTOR; COCAINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ANAL INTERCOURSE; ARTICLE; BEHAVIOR CHANGE; CENTRAL AMERICA; CHLAMYDIASIS; COITUS; CONTRACEPTIVE BEHAVIOR; DRUG EFFICACY; DRUG USE; FEMALE; GONORRHEA; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY (TOPIC); NORTH AMERICA; ORAL SEX; PHASE 2 CLINICAL TRIAL (TOPIC); PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SOUTH AMERICA; SYPHILIS; UNPROTECTED SEX; VACCINATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; AIDS VACCINES; CARIBBEAN REGION; DOUBLE-BLIND METHOD; DRUG CARRIERS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NORTH AMERICA; PLACEBOS; PREGNANCY; RISK-TAKING; SEXUAL BEHAVIOR; SOUTH AMERICA; SUBSTANCE-RELATED DISORDERS;

EID: 84879855649     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328360c83e     Document Type: Article

References (28)

1. Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, et al. HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39:90-101.
2. Djomand G, Metch B, Zorrilla CD, Donastorg Y, Casapia M, Villafana T, et al. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr 2008; 48:82-89.
3. Chiasson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991; 5:1121-1126.
4. Cohen E, Navaline H, Metzger D. High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women. J Psychoactive Drugs 1994; 26:233-241.
5. Cossa HA, Gloyd S, Vaz RG, Folgosa E, Simbine E, Diniz M, et al. Syphilis and HIV infection among displaced pregnant women in rural Mozambique. Int J STD AIDS 1994; 5:117-123.
6. Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548-554.
7. Chirgwin KD, Feldman J, Dehovitz JA, Minkoff H, Landesman SH. Incidence and risk factors for heterosexually acquired HIV in an inner-city cohort of women: temporal association with pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:295-299.
8. Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS 2009; 23:1255-1259.
9. Keating MA, Hamela G, Miller WC, Moses A, Hoffman IF, Hosseinipour MC. High HIV incidence and sexual behavior change among pregnant women in Lilongwe, Malawi: implications for the risk of HIV acquisition. PloS One 2012; 7:e39109.
10. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-1893.
11. Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis 2012; 206:258-266.
12. Koblin BA, Mayer KH, Noonan E, Wang CY, Marmor M, Sanchez J, et al. Sexual risk behaviors, circumcision status and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: Step Study. J Acquir Immune Defic Syndr 2012; 60:405-413.
13. Brewer TH, Zhao W, Metsch LR, Coltes A, Zenilman J. High-risk behaviors in women who use crack: knowledge of HIV serostatus and risk behavior. Ann Epidemiol 2007; 17:533-539.
14. Tortu S, Beardsley M, Deren S, Williams M, McCoy HV, Stark M, et al. HIV infection and patterns of risk among women drug injectors and crack users in low and high sero-prevalence sites. AIDS Care 2000; 12:65-76.
15. DeBeck K, Kerr T, Li K, Fischer B, Buxton J, Montaner J, et al. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Can Med Assoc J 2009; 181:585-589.
16. Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, et al. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 2001; 153:619-627.
17. Koblin BA, Hoover DR, Xu G, Frye V, Latka MH, Lucy D, et al. Correlates of anal intercourse vary by partner type among substance-using women: baseline data from the UNITY study. AIDS Behav 2010; 14:132-140.
18. Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH. Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team. J Acquir Immune Defic Syndr 2000; 24:393-398.
19. Latka MH, Wilson TE, Cook JA, Bacon MC, Richardson JL, Sohler N, et al. Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV Study. J Substance Abuse Treatment 2005; 29:329-337.
20. Jemmott LS, Jemmott JB 3rd, O'Leary A. Effects on sexual risk behavior and STD rate of brief HIV/STD prevention interventions for African American women in primary care settings.Am J Public Health 2007; 97:1034-1040.
21. Wilson TE, Jaccard J, Levinson RA, Minkoff H, Endias R. Testing for HIV and other sexually transmitted diseases: implications for risk behavior in women. Health Psychol 1996; 15:252-260.
22. Social-cognitive theory mediators of behavior change in the National Institute of Mental Health Multisite HIV Prevention Trial. Health Psychol 2001; 20:369-376.
23. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, et al. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr 2010; 53:606-613.
24. Karim QA, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu- Natal, South Africa. Int J Epidemiol 2011; 40:922-930.
25. Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, et al. HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial. Sexual Transm Dis 2009; 36:129-133.
26. Dixon D, Peters M, Saul J. HIV sexual risk behavior among Puerto Rican women. Healthcare Women Int 2003; 24:529-543.
27. Saul J, Norris FH, Bartholow KK, Dixon D, Peters M, Moore J. Heterosexual risk for HIV among Puerto Rican women: does power influence self-protective behavior? AIDS Behav 2000; 4:361-371.
28. Latka MH, Fielding K, Gray GE, Bekker LG, Nchabeleng M, Mlisana K, et al. Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women. PloS One 2012; 7:e31387.